Home Cart Sign in  
Chemical Structure| 1120-95-2 Chemical Structure| 1120-95-2

Structure of 1120-95-2

Chemical Structure| 1120-95-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1120-95-2 ]

CAS No. :1120-95-2
Formula : C4H3ClN2
M.W : 114.53
SMILES Code : ClC1=NN=CC=C1
MDL No. :MFCD06801356
InChI Key :IBWYHNOFSKJKKY-UHFFFAOYSA-N
Pubchem ID :11274989

Safety of [ 1120-95-2 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Application In Synthesis of [ 1120-95-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1120-95-2 ]

[ 1120-95-2 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 504-30-3 ]
  • [ 1120-95-2 ]
YieldReaction ConditionsOperation in experiment
63% With trichlorophosphate; a 3-Chloropyridazine 3-(2H)-Pyridazinone (1 g, 10.4 mmol) was treated with phosphorous oxychloride (10 mL) at 90° C. for 4 H. The mixture was poured into ice (100 g), basified with 50percent NaOH, and extracted with CH2 Cl2 (3*150 mL). The combined organic extracts were dried (MgSO4) and concentrated to give the title compound as a yellow solid (750 mg, 63percent): MS (ES) m/e 115 [M+H]+.
46% Step A 3-(2H)-pyridazinone (5.0 g, 52.0 mmole) was treated with phosphorous oxychloride (17 ml, 179 mmole) at 85° C. for 4.5 hours. The mixture was poured into 400 g ice/H2O, basified (pH>10) with 50percent NaOH, and extracted with EtOAc (4*). The combined organic layers were washed with brine, dried (MgSO4), and concentrated. The material was run through a Hak-Pak (SiO2, 1:1 hexanes/EtOAc) to give 2.8 g (46percent) of 3-chloropyridazinone.
Example 130 2-Chloro-N-(1 -hydroxy-cyclohexylmethyl)-5-(pyridazin-3-yloxy)- benzamide130.1 3-Chloro-pyridazineA suspension of 3(2H)-pyridazinone (1 g) in phosphorus oxychloride (0.970 mL) was heated to 80°C for 18h. The reaction mixture was evaporated off and the residue was treated with ice 2M solution of NaOH and extracted with EtOAc. The organic phase was washed with brine, dried over MgS04 and concentrated in vacuo to give 857 mg of the crude titled compound as a purple solid.1H NMR ((CD3)2SO) delta: 9.27 (d, J = 4.7 Hz, 1 H), 7.95 (d, J = 8.7 Hz, 1 H), 7.82 (dd, 4 = 8.7 Hz, J2 = 4.7 Hz, 1 H)
With trichlorophosphate; at 80℃; for 18h; 130.1 3-Chloro-pyridazine A suspension of 3(2H)-pyridazinone (1 g) in phosphorus oxychloride (0.970 mL) was heated to 80° C. for 18 h. The reaction mixture was evaporated off and the residue was treated with ice 2M solution of NaOH and extracted with EtOAc. The organic phase was washed with brine, dried over MgSO4 and concentrated in vacuo to give 857 mg of the crude titled compound as a purple solid. 1H NMR ((CD3)2SO) delta: 9.27 (d, J=4.7 Hz, 1H), 7.95 (d, J=8.7 Hz, 1H), 7.82 (dd, J1=8.7 Hz, J2=4.7 Hz, 1H)

  • 2
  • [ 1120-95-2 ]
  • [ 124-41-4 ]
  • [ 19064-65-4 ]
  • 3
  • [ 1120-95-2 ]
  • [ 141-52-6 ]
  • [ 62567-44-6 ]
  • 4
  • [ 1120-95-2 ]
  • [ 289-80-5 ]
YieldReaction ConditionsOperation in experiment
With potassium acetate; palladium diacetate; bis(pinacol)diborane; tricyclohexylphosphine; In 1,4-dioxane; at 110℃; for 0.166667h;Inert atmosphere; General procedure: The Miyaura borylation reactions were carried out as follows: Chloropyrazines (3.0 mmol), B2pin2 (838 mg, 3.3 mmol), Pd(OAc)2 (14 mg, 2 mol percent), PCy3 (34 mg, 4 mol percent) and AcOK (750 mg, 7.5 mmol) was added in a 50 ml three necked flask fitted with a condenser, and dioxane (15 ml) was added at last. Then the reaction mixture was stirred at a preheated oil bath 110 oC under nitrogen atmosphere for 10 min. After complete completion of starting material checked by TLC, the reaction was cooled to room temperature, EtOAc (20 ml) was added. After filtration through Celite ® and concentration under vacuo, the resulting residue was precipitated from n-hexane:Et2O to afford corresponding boronic esters.
  • 6
  • [ 1120-95-2 ]
  • [ 40972-16-5 ]
  • 7
  • [ 1120-95-2 ]
  • [ 62567-44-6 ]
  • 8
  • [ 1120-95-2 ]
  • [ 2947-61-7 ]
  • [ 81102-51-4 ]
  • 9
  • [ 1120-95-2 ]
  • [ 7569-26-8 ]
  • [ 143998-61-2 ]
  • 10
  • [ 1120-95-2 ]
  • [ 140-29-4 ]
  • [ 66978-40-3 ]
  • 11
  • [ 1120-95-2 ]
  • [ 104-47-2 ]
  • [ 81102-52-5 ]
  • 12
  • [ 1120-95-2 ]
  • [ 3218-49-3 ]
  • [ 81102-53-6 ]
  • 13
  • [ 1120-95-2 ]
  • [ 140-53-4 ]
  • [ 81102-50-3 ]
  • 14
  • [ 1120-95-2 ]
  • [ 19493-09-5 ]
  • 3-[(Triphenyl-λ5-phosphanylidene)-methyl]-pyridazine [ No CAS ]
  • 16
  • [ 1120-95-2 ]
  • [ 10034-85-2 ]
  • red phosphorus [ No CAS ]
  • [ 289-80-5 ]
  • 18
  • [ 504-30-3 ]
  • [ 10025-87-3 ]
  • [ 1120-95-2 ]
  • 19
  • pyridazone-(3) [ No CAS ]
  • [ 1120-95-2 ]
  • 20
  • [ 1120-95-2 ]
  • [ 86945-25-7 ]
  • [2-(1-benzyl-piperidin-4-yl)-ethyl]-pyridazin-3-yl-amine [ No CAS ]
  • 21
  • [ 504-30-3 ]
  • [ 1120-95-2 ]
YieldReaction ConditionsOperation in experiment
92% With trichlorophosphate; at 60℃; for 1.5h; Preparation 118: 3-Chloro-pyridazine (Prepi 18); A mixture of pyridazin-3-ol (1.9 g, 19.8 mmol) in POCI3 (19 ml) was heated to 600C for 90 minutes. After cooling to room temperature, the reaction was quenched in ice/water and neutralized with solid NaHCO3. The product was extracted with ethyl acetate, the organic phase was washed with brine, dried (Na2SO4) and evaporated to give 2.1 g of the title compound as a brown solid (92percent yield). MS (ES) (m/z): 115.1 [M+H]+.
67% In trichlorophosphate; 3-chloropyridazine A solution of 3-hydroxypyridazine (96 g, 1 mol) in phosphorous oxychloride (800 ml) is refluxed on an oil bath for 4 h. The excess amount of POCl3 is removed in vacuum, the residue is cooled and added to 2 kg of ice. The reaction mixture is then neutralized with aqueous ammonia and extracted with chloroform (4x500 ml). The combined organic extract is washed with brine (3x200 ml), dried over MgSO4 and the solvent is removed in vacuum, yielding the desired product (76 g, 67percent).
  • 22
  • [ 1120-95-2 ]
  • [ 65202-53-1 ]
YieldReaction ConditionsOperation in experiment
55% Preparation 119: 3-lodo-pyridazine (Prep119); A mixture of <strong>[1120-95-2]3-chloro-pyridazine</strong> (Prep118, 2.1 g, 18.4 mmol) and NaI, (4 g, 26.8 mmol) in57percent Hlaq (16 ml) was warmed at 50°C for 24 hours. After cooling the solution was basified with solid NaHCO3 and extracted with ethyl acetate. The organic phase was dried <n="125"/>(Na2SO4) and evaporated to give 2.1 g of the title compound as a light brown powder(55percent yield).MS (ES) (mlz): 207.2 [M+H]+.
  • 23
  • [ 1120-95-2 ]
  • [ 18144-47-3 ]
  • C15H17N3O2 [ No CAS ]
  • 24
  • [ 1120-95-2 ]
  • [ 2835-96-3 ]
  • [ 871020-44-9 ]
YieldReaction ConditionsOperation in experiment
71% With potassium carbonate; In ISOPROPYLAMIDE; at 180℃; for 0.833333h;Microwave irradiation; Example 143; 5-[(1R)-1-methyl-2-morpholin-4-yl-2-oxoethoxy]-N [3-methyl-4-(pyridazin-3- yloxy)phenyl] quinazolin-4-amine; Starting aniline: 3-methyl-4-(pyridazin-3-yloxy)aniline. Yield: 89 mg; 56percent on a 0.33 mmol scale. NMR Spectrum: (400 MHz) 1.58 (d, 3H), 2.13 (s, 3H), 3.8-3.3 (m, 8H), 5.88 (q, 1H), 7.17 (d, 1H), 7.30 (d, 1H), 7.36 (d, 1H), 7.47 (d, 1H), 7.75 (m, 2H), 7.90 (dd, 1H), 8.00 (d, 1H), 8.53 (s, 1H), 8.99 (m, 1H), 11.09 (s, 1H); Mass spectrum: MH+ 487; The 3-methyl-4-(pyridazin-3-yloxy)aniline used as starting material was prepared as follows: A mixture of 4-amino-2-methylphenol (550 mg, 4.47 mmol), <strong>[1120-95-2]3-<strong>[1120-95-2]chloropyridazine</strong></strong> (510 mg, 4.47 mmol; Libermann et al., Bull. Soc. Chem. Fr., 1962, 1735), potassium carbonate (926 mg, 6.71 mmol) in DMA (10 ml) was irradiated in a Personal Chemistry EMRYSNo. Optimizer EXP microwave synthesisor at 180 °C for 50 minutes. After cooling, the mixture was partitioned with water and dichloromethane. After filtration of the insoluble, the organic layer was washed with water and brine and dried over magnesium sulfate. After evaporation of the solvents, the residue was purified by chromatography on silica gel (eluant: ethyl acetate) to give 3-methyl-4- (pyridazin-3-yloxy)aniline a brown solid (638 mg, 71percent) ; Mass spectrum: MH+ 202.
  • 25
  • [ 1120-95-2 ]
  • [ 87199-17-5 ]
  • 4-[Pyridazin-3-yl]-Benzaldehyde [ No CAS ]
YieldReaction ConditionsOperation in experiment
93% With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In ethanol; toluene; for 20h;Heating / reflux; Step B Ethanol (10 ml) and 1.0M Na2CO3 (18 ml) were added to a suspension of the compound from step A (2.8 g, 24.0 mmole), 4-formylphenylboronic acid (4.7 g, 31.2 mmole), and tetrakis(triphenylphosphine)palladium(0) (1.4 g, 1.2 mmole0 in toluene (35 ml). The mixture was refluxed for 20 hours then cooled, diluted with EtOAc, washed with NaHCO3, washed with brine, dried (MgSO4) and concentrated. Purification by chromatography (SiO2, 4:1 hexanes/EtOAc) yielded 4.1 g (93percent) of 4-(3-pyridazinyl)benzaldehyde.
  • 26
  • [ 1120-95-2 ]
  • C24H28BNO2S [ No CAS ]
  • (+)-4-benzo[b]thiophen-5-yl-2-methyl-7-pyridazin-3-yl-1,2,3,4-tetrahydroisoquinoline [ No CAS ]
YieldReaction ConditionsOperation in experiment
With sodium carbonate;(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; In water; N,N-dimethyl-formamide; at 100℃; for 5h; Step C: A mixture of the ester (5.2 g, crude, 5.9 mmol) obtained from Step B, <strong>[1120-95-2]3-pyridazinylchloride</strong> (1.0 g, 8.8 mmol), Na2CO3 (1.93 g, 17.9 mmol), H2O (5 mL), and DMF (25 mL) was purged with argon. PdCl2dppf (722 mg, 0.88 mmol) was added. The mixture was heated at 100° C. for 5 hours. After cooled to room temperature, the reaction was diluted with dichloromethane (100 mL), and filtered through celite. The filtrate was washed with water (200 mL) and brine (200 mL), dried (Na2SO4) and concentrated. The residue was purified by a medium pressure chromatography (eluent: MeOH/EtOAc 1:9) to give (+)-4-benzo[b]thiophen-5-yl-2-methyl-7-pyridazin-3-yl-1,2,3,4-tetrahydroisoquinoline (390 mg, 19percent for three steps) as a light-brown oil. It was dissolved in MeOH (5 mL) at room temperature, and to this solution was added fumaric acid (125 mg, 1.07 mmol). The solution was concentrated to about 2 mL. Water (20 mL) was added to the solution. The resulting suspension was lyophilized on a freeze dryer overnight to give (+)-4-benzo[b]thiophen-5-yl-2-methyl-7-pyridazin-3-yl-1,2,3,4-tetrahydroisoquinoline, fumarate salt (355 mg, 59percent, >99percent AUC HPLC) as a light-brown solid: [CC]25D+7.3° (c 0.07, methanol); mp 122-124° C.; 1H NMR (500 MHz, CD3OD) delta 9.15 (d, J=4.9 Hz, 1H), 8.17 (d, J=8.7 Hz, 1H), 8.04 (s, 1H), 7.93-7.88 (m, 2H), 7.80-7.77 (m, 2H), 7.61 (d, J=5.5 Hz, 1H), 7.35 (d, J=5.5 Hz, 1H), 7.22 (d, J=8.3 Hz, 1H), 7.11 (d, J=8.2 Hz, 1H), 6.71 (s, 4H), 4.71 (dd, J=10.5, 6.5 Hz, 1H), 4.52 (d, J=15.1 Hz, 1H), 4.44 (d, J=15.1 Hz, 1H), 3.73 (dd, J=12,0, 6.0 Hz, 1H), 3.42-3.38 (m, 1H), 2.91 (s, 3H); ESI-MS 358 [M+H]+; Anal Calcd. For C22H19N3S.1.75C4H4O4: C, 62.13; H, 4.67; N, 7.50. Found: C, 61.80; H, 4.81; N, 7.17.
  • 27
  • [ 1120-95-2 ]
  • [ 811-93-8 ]
  • 2-amino-2-methyl-N-(3-pyridazinyl)propylamine [ No CAS ]
YieldReaction ConditionsOperation in experiment
85% With N-ethyl-N,N-diisopropylamine; at 170℃; Reference example 99:; 2-Amino-2-methyl-N-(3-pyridazinyl)propylamine[0311] To <strong>[1120-95-2]3-<strong>[1120-95-2]chloropyridazine</strong></strong> (770 mg, 6.70 mmol) described in WO 97/24124 were added 1,2-diamino-2-methylpropane (1.39 mL, 13.5 mmol) and [0312] N,N-diisopropylethylamine (3.48 mL, 20.0 mmol), and the mixture was stirred at 170 DEG C overnight. The reaction mixture was concentrated, and the obtained residue was purified by silica gel column chromatography [Chromatrex (registered trademark)NH Fuji Silysia, ethyl acetate to ethyl acetate/methanol=9/1] to obtain the title compound (948 mg, 5.71 mmol).yield: 85percent<1>H NMR (CDCl3) delta (ppm): 8.50 (1H, dd, J = 4.3, 1.4 Hz), 7.13 (1H, dd, J = 8.9, 4.3 Hz), 6.71 (1H, dd, J = 8.9, 1.4 Hz), 5.43 (1H, m), 3.36 (2H, d, J = 5.9 Hz), 1.20 (6H, s).APCIMS (m/z): 167 (M + H)<+>
  • 28
  • [ 1120-95-2 ]
  • [ 109-76-2 ]
  • [ 792883-45-5 ]
  • N-cyano-N'-[3-(3-pyridazinylamino)propyl]guanidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
With sodium ethanolate; In ethanol; EXAMPLE 106 Reacting <strong>[1120-95-2]3-<strong>[1120-95-2]chloropyridazine</strong></strong> with 1,3-diaminopropane in ethanol containing sodium ethoxide according to the procedure of Example 89 gives 3-(3-aminopropylamino)-pyridazine. Using this intermediate as the starting material in the procedure of Example 18 gives N-cyano-N'-[3-(3-pyridazinylamino)propyl]guanidine. The ingredients are mixed and filled into a hard gelatin capsule. Compounds of formula I where A is such that there is formed together with the carbon atom shown a five membered unsaturated heterocyclic ring having one nitrogen atom, one sulphur or oxygen atom and three carbon atoms, said unsaturated heterocyclic ring being thiazole, isothiazole, oxazole or isoxazole, and Y is oxygen or sulphur (sulphur is preferred) are exemplified by the following examples.
  • 29
  • [ 1120-95-2 ]
  • [ 792883-45-5 ]
  • [ 109-76-2 ]
  • N-benzoyl-N'-[3-(3-pyridazinylamino)propyl]-thiourea [ No CAS ]
YieldReaction ConditionsOperation in experiment
EXAMPLE 108 Treating 3-(3-aminopropylamino)pyridazine, prepared by reacting <strong>[1120-95-2]3-<strong>[1120-95-2]chloropyridazine</strong></strong> with 1,3-diaminopropane, with benzoyl isothiocyanate by the procedure of Example 46 gives N-benzoyl-N'-[3-(3-pyridazinylamino)propyl]-thiourea.
  • 30
  • [ 1120-95-2 ]
  • C27H32BNO2 [ No CAS ]
  • C25H23N3 [ No CAS ]
YieldReaction ConditionsOperation in experiment
With sodium carbonate;(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; In water; N,N-dimethyl-formamide; at 100℃; Step D: To a disposable sealed tube were added the product of Step C (296 mg, 0.72 mmol) as a solution in anhydrous DMF (3 mL), sodium carbonate (228 mg, 2.2 mmol) as a solution in H2O (1.4 mL), and <strong>[1120-95-2]3-<strong>[1120-95-2]chloropyridazine</strong></strong> (188 mg, 1.6 mmol). The reaction mixture was degassed by a subsurface sparge with Ar for 2 minutes. PdCl2(dppf).CH2Cl2 (35 mg, 0.043 mmol) was then added under Ar. The reaction was heated to 100° C. and allowed to stir overnight. TLC analysis showed that the reaction had gone to completion. After cooling to room temperature, the reaction mixture was diluted with H2O, then extracted with ethyl acetate (3.x.). The combined extracts were dried over sodium sulfate, filtered, and concentrated in vacuo. Purification via flash column chromatography (95:5 CH2Cl2/MeOH) yielded the desired pyridazine (128 mg, 49percent over two steps) as a light brown oil: [alpha]25D -2.9° (c 0.07, methanol); 1H NMR (500 MHz, CDCl3) delta 9.14 (dd, J=5.0, 2.0 Hz, 1H), 8.03 (d, J=2.0 Hz, 1H), 7.88-7.86 (m, 2H), 7.82 (dd, J=8.5, 1.5 Hz, 1H), 7.80-7.79 (m, 1H), 7.72-7.70 (m, 1H), 7.64-7.61 (m, 1H), 7.52-7.50 (m, 1H), 7.50-7.48 (m, 2H), 7.40 (dd, J=8.5, 1.5 Hz, 1H), 6.87-6.80 (br, 1H), 4.57 (d, J=9.5 Hz, 1H), 4.11-4.05 (m, 1H), 3.92 (d, J=14.5 Hz, 1H), 3.21-3.16 (m, 1H), 3.09-3.03 (m, 1H), 2.53-2.46 (m, 1H), 2.41 (s, 3H), 2.28-2.22 (m, 1H); ESI MS m/z=366 [C25H23N3+H]+.
  • 31
  • [ 1120-95-2 ]
  • [ 947372-31-8 ]
  • (3R,4R,5S)-1-[(3S,4S)-4-(5-chloropyridin-2-yl)-1-pyridazin-3-ylpyrrolidin-3-yl]carbonyl}-3,5-dimethyl-4-pyridin-2-ylpiperidin-4-ol [ No CAS ]
YieldReaction ConditionsOperation in experiment
27% With triethylamine; cesium fluoride; In dimethyl sulfoxide; at 100℃; Example 9(3R,4R,5S)-1-(r(3S.4S)-4-(5-chloropyridin-2-yl)-1-pyridazin-3-ylPyrrolidin-3-vncarbonyl)-3.5-dimethyl-4- pyridin-2-ylpiperidin-4-olTo a solution of (3R,4R,5S)-1-[(3S,4S)-4-(5-chloropyridin-2-yl)pyrrolidin-3-yl]carbonyl}-3,5-dimethyl-4- pyridin-2-ylpiperidin-4-ol (prepared by the same method as used for the amine of preparation 10, starting from (3R,4s,5S)-3,5-dimethyl-4-pyridin-2-ylpiperidin-4-ol, prepared according to international patent application publication number WO 2005/077935) (50 mg, 0.12 mmol) in DMSO (2 ml_) was added 3- <strong>[1120-95-2]chloropyridazine</strong> (28 mg, 0.24 mmol), caesium fluoride (18 mg, 0.12 mmol) and triethylamine (0.05 ml_, 0.36 mmol). The mixture was stirred at 100°C under nitrogen overnight. The reaction mixture was diluted with 10 mL ethyl acetate and washed with 3 x 20 m L of water. The combined aqueous extracts were extracted with 10 mL ethyl acetate and the combined organic extracts were washed with 10 mL brine, dried (MgSO4) and the solvent was removed in vacuo. The residue was purified by column chromatography (silica) eluting with dichloromethane/methanol/aq. ammonia 99/1/0.1, increasing polarity to 95/5/0.5. This gave the title compound (16 mg, 27percent) as a yellow gum. 1H NMR (CD3OD, 400 MHz) delta 0.20-0.37 (6H, 4 x d), 0.91-1.13, 1.67-1.76 and 1.94-2.09 (2H, 3 x m), 2.54-2.62 (1 H, m), 2.87-2.93 and2.99-3.05 (1 H, 2 x m), 3.61-3.74 (3H, m), 3.86-4.08 (4H, m), 4.20-4.26 (1H, m), 6.83-6.88 (1H, m), 7.11-7.44 (4H, m), 7.63-7.78 (2H, m), 8.30-8.46 (3H, m); LRMS (El+) 493 [MH+].
  • 32
  • [ 1120-95-2 ]
  • (trans)-ethyl 2-oxo-1-oxa-3-azaspiro[4.5]decane-8-carboxylate [ No CAS ]
  • ethyl trans-2-oxo-3-(3-pyridazinyl)-1-oxa-3-azaspiro[4.5]decane-8-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
With potassium phosphate; copper(l) iodide; trans-1,2-cyclohexanediamine; at 120℃; for 8h; Intermediate 23; Ethyl (trans^-oxo-S-O-pyridazinvD-i-oxa-S-azaspiroK.deltaidecane-delta-carboxylatet; Ethyl (trans)-2-oxo-1-oxa-3-azaspiro[4.5]decane-8-carboxylate (prepared in an analogous fashion to Intermediate 15, 250 mg, 1.100 mmol), <strong>[1120-95-2]3-<strong>[1120-95-2]chloropyridazine</strong></strong> (for a preparation see WO2001007416, 126 mg, 1.100 mmol), trans-1 ,2-diaminocyclohexane (0.066 ml, 0.550 mmol), copper(l) iodide (105 mg, 0.550 mmol), K3PO4 (1168 mg, 5.50 mmol) were collected and shaken at 120 0C for 8 h. Solvent was removed under vacuum, rinsed with DCM (10 ml) and filtered over a separation tube. The resulting solution was then purified with Biotage SP1 , over a Silica 25M column, eluting with a gradient of DCM and Et2O. The title compound was eluted with ca 15percent Et2O and recovered as a colourless solid (1 10 mg). <n="38"/>1H NMR (400 MHz, CDCI3): delta 8.97 (dd, 1 H), 8.56 (dd, 1 H), 7.50 (dd, 1 H), 4.20 (s, 2H), 2.55-2.46 (m, 1 H), 2.10-1.74 (m, 8h); UPLC-MS: 0.62 m, 306 [M+H]+.
  • 33
  • [ 1120-95-2 ]
  • [ 1084812-05-4 ]
  • [ 1084812-07-6 ]
YieldReaction ConditionsOperation in experiment
With caesium carbonate;(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; In water; N,N-dimethyl-formamide; at 100℃; for 2h;Product distribution / selectivity; The boronate ester (19 g, crude) from Step F above, 3-chloro- pyridazine (4.8 g, 42 mmol), and cesium carbonate (21 g, 63 mmol) were suspended in DMF (120 mL) and water (30 mL). The mixture was purged with argon. 1,1'- Bis(diphenylphosphino)ferrocenedichloropalladium (240 mg, 0.33 mmol) was added to the mixture. The mixture was heated at 1000C for 2 hours. After cooling to room temperature, the reaction mixture was diluted with dichloromethane, and filtered through a pad of Celite. The filtrate was washed with water, brine, dried over sodium sulfate and concentrated. The residue was purified by flash chromatography (98:1.8:0.2 to 95:4.5:0.5 dichloromethane/methanol/concentrated ammonium hydroxide) to give 5-(tert-butyldimethylsilyloxy)-2-methyl-8-(pyridazin-3-yl)-2, 3,4,5- tetrahydro-lH-benzo[c]azepine (4.7 g, 40percent for 2 steps) as an oil. This oil was resolved using Chiralcel OD column (eluente :80 etaep:20 IPA:0.1 DEA) to give (+)- enantiomer (2.3 g, 98percent, ([alpha]25D, +26.9° (C, 0.29 Methanol) and (-)-enantiomer (2.3 g, 98percent, [alpha]25D, -23.2° (C, 0.28 Methanol)): 1H NMR (CDCl3, 300 MHz) delta 9.15 (d, J= 4.8 Hz, IH), 7.91-7.84 (m, 3H), 7.54-7.50 (m, 2H), 4.96 (t, J= 5.2 Hz, IH), 4.26-4.05 (m, IH), 3.85-3.73 (m, IH), 3.30-3.21 (m, IH), 2.97-2.91 (m, IH), 2.32 (s, 3H) 1.95- 1.85 (m, 2H), 0.91 (s, 9H), 0.097-0.085 (m, 6H); ESI MS m/z 370 [M+H]+.The boronate ester (5.5 g, crude) from Step F above, 3-chloro- pyridazine (2.0 g, ~16 mmol), and cesium carbonate (4.2 g, 13 mmol) were suspended in DMF (30 mL) and water (8 mL). The mixture was purged with argon. 1,1'- Bis(diphenylphosphino)ferrocenedichloropalladium (400 mg, 0.52 mmol) was added to the mixture. The mixture was heated at 1000C for 2 hours. After cooling to room temperature, the reaction mixture was diluted with dichloromethane, and filtered through a pad of celite. The filtrate was washed with water, brine, dried over sodium sulfate and concentrated. The residue was purified by flash chromatography <n="83"/>(98:1.8:0.2 to 95:4.5:0.5 dichloromethane/methanol/concentrated ammonium hydroxide) to give 5-(tert-butyldimethylsilyloxy)-2-methyl-8-(pyridazin-3-yl)-2, 3,4,5- tetrahydro-lH-benzo[c]azepine (1.3 g, 55percent for 2 steps) as an brown oil: 1H NMR (CDCl3, 300 MHz) delta 9.15 (d, J= 4.8 Hz, IH), 7.91-7.84 (m, 3H), 7.54-7.50 (m, 2H), 4.96 (t, J= 5.2 Hz, IH), 4.20-4.10 (m, IH), 3.85-3.73 (m, IH), 2.97-2.91 (m, IH), 2.32 (s, 3H) d, J= 7.9 Hz, IH), 7.24 (d, J= 7.9 Hz, IH ), 4.82 (t, J= 4.9 Hz, IH), 3.64-3.61 (m, IH), 3.27-3.18 (m IH), 2.36 (s, 3H), 1.95-1.85 (m, 2H), 1.80-1.63 (m, 2H), 0.91 (s, 9H), 0.097-0.085 (m, 6H); ESI MS m/z 370 [M+H]+.
  • 34
  • [ 1120-95-2 ]
  • [ 958449-05-3 ]
  • [ 958448-31-2 ]
YieldReaction ConditionsOperation in experiment
With triethylamine; In 1,4-dioxane; ethanol; at 130 - 155℃; for 15h; [Example 3] Synthesis of (+-)-3',5',8',11'-tetraaza-11'-(6-chloronaphthalen-2-ylsulfonyl)-1-(3-pyridazinyl) spiro[piperidine-4,6'-tricyclo[6.4.0.01,5]dodecane]-4',9'-dione The compound obtained in Example 2, <step 4> (20 mg) was suspended in dioxane (1.5 ml) and ethanol (1.5 ml). After adding triethylamine (17 mul) and <strong>[1120-95-2]3-<strong>[1120-95-2]chloropyridazine</strong></strong> (19 mg), the mixture was stirred in a sealed tube at 130 to 140°C for 2 hours, and at 140 to 155°C for 5.5 hours. Another portion of <strong>[1120-95-2]3-<strong>[1120-95-2]chloropyridazine</strong></strong> (9 mg) was added, and the mixture was stirred at 140 to 155°C for 7.5 hours. The solvent was evaporated under reduced pressure, and the residue was purified by preparative thin-layer chromatography [Chromatorex NH.(TM).)](developing solvent: methylene chloride / methanol = 19/1) to produce the title compound (8 mg) as a white solid.
  • 35
  • [ 1120-95-2 ]
  • 6,6-dimethyl-2-(6-hydroxy-2,3-dihydrobenzo[1,4]oxazin-4-yl)-6,7-dihydro-[1,3]thiazolo[5,4-c]pyridin-4(5H)-one [ No CAS ]
  • [ 1160102-35-1 ]
YieldReaction ConditionsOperation in experiment
23% With caesium carbonate; In 1-methyl-pyrrolidin-2-one; at 110℃; for 12h; INTERMEDIATE 306,6-Dimethyl-2-[6-(pyrida2in-3-yloxy)-2,3-dihvdro-4H-l,4-benzoxazin-4-yl]-6,7- dihvdro[ 1 ,3]thiazolor5,4-clpyridin-4(5H)-oneA mixture of Intermediate 17 (53 mg, 0.16 mmol), cesium carbonate (105 mg,0.32 mmol) and 3,6-di<strong>[1120-95-2]chloropyridazine</strong> (24 mg, 0.16 mmol) in NMP (2 mL) was heated to 1100C for 12 h. After cooling to r.t. it was concentrated in vacuo. Purification by preparative etaPLC (Method 5) gave the title compound (15 mg, 23percent) as an off-white solid. deltaeta (CDCl3) 8.94 (IH, dd, J4.5, 1.3 Hz), 8.02 (IH, d, J2.4 Hz), 7.49 (IH, dd, J8.9,4.5 Hz), 7.19 (IH, dd, J 8.9, 1.3 Hz), 6.89-7.03 (2H, m), 5.21 (IH, s), 4.31-4.39 (2H, m),4.09-4.18 (2H, m), 2.86 (2H, s), 1.37 (6H, s).
 

Historical Records

Technical Information

Categories

Similar Product of
[ 1120-95-2 ]

Chemical Structure| 856847-77-3

A135523 [856847-77-3]

3-Chloropyridazine hydrochloride

Reason: Free-Salt